Results 181 to 190 of about 21,132 (237)
Gastroenterology, 2022 Gastroparesis is characterized by symptoms suggestive of, and objective evidence of, delayed gastric emptying in the absence of mechanical obstruction. This review addresses the normal emptying of solids and liquids from the stomach and details the myogenic and neuromuscular control mechanisms, including the specialized function of the pyloric ...
Michael Camilleri, Kenton M. Sanders
openaire +3 more sources
Clinical Gastroenterology and Hepatology, 2022 The Gastroparesis Clinical Research Consortium (GpCRC) is a multicenter coalition created and funded by the National Institutes of Diabetes and Digestive and Kidney Disorders (NIDDK), with a mission to advance understanding of the pathophysiology of ...
Pankaj J Pasricha +2 more
exaly +4 more sources
, 2011 Also has ISBN 1607615525 ; 9781607615521 ; Gastric emptying is frequently disordered in patients with long-standing type 1 and type 2 diabetes mellitus. While patients with diabetes present with similar symptoms to those with idiopathic gastroparesis, the relationship between gastric emptying and glycemic control represents an important additional ...
Rayner, C., Jones, K., Horowitz, M.
core +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Diabetic Gastroparesis and Nondiabetic Gastroparesis
Gastrointestinal Endoscopy Clinics of North America, 2019Gastroparesis can be divided into diabetic and nondiabetic, and the 3 main causes of gastroparesis are diabetic, postsurgical, and idiopathic. Delayed gastric emptying is the main manifestation of motility disorders for gastroparesis. Symptoms of gastroparesis are nonspecific and severity can vary.
Shanshan Shen +2 more
exaly +3 more sources
Gastroenterology Clinics of North America, 2015 Gastroparesis is a complication of long-standing type 1 and type 2 diabetes mellitus. Symptoms associated with gastroparesis include early satiety, prolonged postprandial fullness, bloating, nausea and vomiting, and abdominal pain. Mortality is increased in patients with diabetic gastroparesis.
Kenneth L, Koch, Jorge, Calles-Escandón
openaire +4 more sources
United European Gastroenterology Journal, 2022 Background/Objectives The global epidemiology of gastroparesis is unknown. The European UEG and European Society for Neurogastroenterology and motility consensus defines Gastroparesis as a condition characterized by delayed gastric emptying in the ...
Karen Van Den Houte +2 more
exaly +2 more sources
Current Opinion in Gastroenterology, 2021
Purpose of review This review highlights recent research advances regarding the pathophysiology and treatment of gastroparesis. Recent findings Differences in brain activity have been identified on functional MRI imaging in gastroparesis patients with nausea.
David J, Cangemi, Brian E, Lacy
openaire +2 more sources
Purpose of review This review highlights recent research advances regarding the pathophysiology and treatment of gastroparesis. Recent findings Differences in brain activity have been identified on functional MRI imaging in gastroparesis patients with nausea.
David J, Cangemi, Brian E, Lacy
openaire +2 more sources
Gastroparesis and Gastroparesis Syndromes as Neuromuscular Disorders
Seminars in Neurology, 2023AbstractGastroparesis syndromes (GpS) are a spectrum of disorders presenting with characteristic symptoms increasingly recognized as being gastrointestinal (GI) neuromuscular disorders (NMDs). This review focuses on GpS as a manifestation of neurologic disorders of GI NMD.
Le Yu, Naing +4 more
openaire +2 more sources
Clinical Gastroenterology and Hepatology, 2023
Background: Cannabis (Δ9THC), a non-selective cannabinoid receptor (CBR) agonist relieves nausea and pain. Cannabidiol (CBD), a CBR2 inverse agonist with central effects, also reduces gut sensation and inflammation.
Ting Zheng +10 more
semanticscholar +1 more source
Background: Cannabis (Δ9THC), a non-selective cannabinoid receptor (CBR) agonist relieves nausea and pain. Cannabidiol (CBD), a CBR2 inverse agonist with central effects, also reduces gut sensation and inflammation.
Ting Zheng +10 more
semanticscholar +1 more source
Current Neurology and Neuroscience Reports, 2022
Migraine is a chronic and disabling disease affecting a significant proportion of the world's population. There is evidence that gastroparesis, a gastrointestinal (GI) dysmotility disorder in which transit of gastric contents is delayed, can occur in the setting of migraine.
Karissa N, Arca +5 more
openaire +2 more sources
Migraine is a chronic and disabling disease affecting a significant proportion of the world's population. There is evidence that gastroparesis, a gastrointestinal (GI) dysmotility disorder in which transit of gastric contents is delayed, can occur in the setting of migraine.
Karissa N, Arca +5 more
openaire +2 more sources